Medicines in Development for Older Americans

07.03.14 | By

As overall life expectancy continues to grow, so does the number of older Americans, the majority of whom have at least one chronic disease. Chronic diseases not only impact our loved ones living with them, but our families as well and cost the health care system billions of dollars. Prospective medicines currently in the pipeline hold promise to improve health outcomes and provide cost savings.

One-Size-Fits-All Approach to Treating Multiple Sclerosis Hurts Patients

07.02.14 | By

Patients, especially those suffering from chronic conditions, deserve access to the medicines they need to live longer, healthier lives. The Affordable Care Act’s health insurance exchanges and the Essential Health Benefits they’re meant to provide were supposed to ensure patients have access to the treatments they need. But for many, high out-of-pocket costs create a sometimes insurmountable barrier to access.

Multiple Sclerosis By the Numbers Graphic

Rx Response Benefits

07.01.14 | By

We all know that it only takes one storm to have severe impact, which is why we wanted to remind you that Rx Response stands ready to support any disaster that has wide-spread impact to pharmaceutical supply, and that all of our services are offered at no cost to government partners.

Mental Health Disorders Can Affect Anyone and Health Insurance Exchanges Must Provide Needed Medicines

07.01.14 | By

Patients, especially those suffering from chronic conditions, deserve access to the medicines they need to live longer, healthier lives. The Affordable Care Act’s health insurance exchanges and the Essential Health Benefits they’re meant to provide were supposed to ensure patients have access to the treatments they need. But for many, high out-of-pocket costs create a sometimes insurmountable barrier to access.

Mental Health By the Numbers Graphic

Collaborating to Treat Mental Health Patients

06.30.14 | By

As the editorial from Patrick Kennedy and Husseini Manji in USA TODAY discusses why brain research is vital, some of the sentiments echo the discussion from our Mental Health Capitol Hill briefing last week.

From Researcher to Patient Advocate

06.30.14 | By

PhRMA’s 2014 Medicines in Development for Parkinson’s Disease report highlighted the nearly 40 medicines in the pipeline that offer hope for the up to 1.5 million Americans affected by Parkinson’s disease (PD). Today we highlight Sue Dubman, one of those individuals living with PD and her inspirational story.

HIV/AIDS By the Numbers Graphic

Two Steps Forward and One Step Back for HIV/AIDS Patients

06.25.14 | By

Patients, especially those suffering from chronic conditions, deserve access to the medicines they need to live longer, healthier lives. The Affordable Care Act’s health insurance exchanges and the Essential Health Benefits they’re meant to provide were supposed to ensure patients have access to the treatments they need. But for many, high out-of-pocket costs create a sometimes insurmountable barrier to access.

Pages

Subscribe to RSS - Opinion